SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000904454-23-000061
Filing Date
2023-01-27
Accepted
2023-01-27 11:12:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A s13ga_123122-fusion.htm SC 13G/A 31015
  Complete submission text file 0000904454-23-000061.txt   32565
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Subject) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91552 | Film No.: 23560583
SIC: 2836 Biological Products, (No Diagnostic Substances)